Faiz Anwer MD

PubMed

• Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort.
  Hossam M Ali, Sandra Mazzoni, Utkarsh Goel, Jack Khouri, Faiz Anwer
  Blood Cancer Journal. 2026-04-29
• Functional high-risk phenotype predicts poor survival in multiple myeloma independent of front-line treatment: A secondary analysis of CIBMTR data.
  Utkarsh Goel, Catalin Dragomirescu, Saurabh Zanwar, Rafaella Cassano Cassano, Kara I Cicero
  British Journal of Haematology. 2026-04-23
• Assessing pneumonia severity using neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: a cross-sectional comparison with CURB-65 score.
  Muhammad Osama, Ahmad Iftikhar, Mallahat Abdul Baseer, Nazim Khan, Abdul Majid
  Therapeutic Advances in Infectious Disease. 2026-04-20

Abstracts/Posters

• Rapid Infusion Daratumumab Is Safe in Patients with AL Amyloidosis
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary Era
  Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• A Network Meta-Analysis of Clinical Trials Assessing Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Among Young Adults 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Gene Therapy for Thalassemia and Sickle Cell Anemia Poses Acceptable Toxicity and Efficacy: Clinical Outcomes in Forty-Seven Cases 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Pomalidomide Based Regimens for Treatment of Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018